Education + Advocacy = Change

Click a topic below for an index of articles:

New-Material

Home

Donate

Alternative-Treatments

Financial or Socio-Economic Issues

Forum

Health Insurance

Hepatitis

HIV/AIDS

Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors

Occupational Concerns

Our Board

Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

 

If you would like to submit an article to this website, email us at info@heart-intl.net for a review of this paper
info@heart-intl.net

any words all words
Results per page:

“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”

    


 

Artichoke (Cynara Scolymus, Caffeic Acid)

An excerpt from the following article: SILYMARIN COMPLEX FOR LIVER DISORDERS by Michael T. Murray, N.D. published in "Health World" spring 1987

The artichoke has a long folk history in treating many liver diseases. Recent evidence supports this long-time use. The active ingredient in artichoke is cynarin. this compound is found in highest concentrations in the leaves.

Like silymarin, cynara extract has also demonstrated significant liver-protecting and regenerating effects. it also possesses choloeretic effect, promoting the outflow of bile from the liver to the gall-bladder. This is a very important property. If the bile is not being transported adequately to the gallbladder, the liver has an increased risk of being damaged. Choleretics are very useful in the treatment of hepatitis and other liver diseases via this "decongesting" effect.

Choleretics typically lower cholesterol levels via their ability to decrease the synthesis of cholesterol in the liver. Consistent with its choleretic effect, cynara extract has been shown to lower blood cholesterol and triglyceride levels in both human and animal studies.

  


 

CLINICAL TRIALS OF CYNARA SCOLYMUS
In a controlled trial, two groups of 30 patients having elevated serum cholesterol and triglycerides were given either cynarin (500 mg. per day) or a placebo. Cynarin proved to induce a significant reduction of these elevated cholesterol and triglyceride levels. In addition, the patients also displayed a reduction in body weight. This effect was probably a result of cynarin's diuretic activity.

CAFFEIC ACID
It appears cynarin, the active component in artichoke leaves extracts, is not the true active substance. Since cynarin can be broken down into caffeic acid in the gastrointestinal tract, it is conceivable that the true active component is caffeic acid. This compound has demonstrated a significant liver-protecting effect as well as choloeretic activity. Cynara Extract has also demonstrated significant liver-protecting and regenerating effects.

  


 

 

 

Email: